Treatment of pediatric Henoch-Sch?nlein purpura nephritis by a stepwise Chinese medicine scheme: a multicenter clinical study
DING Ying,ZHAI Wensheng,REN Xianqing,ZHANG Xia,LIU Jianping,HE Liyun,XU Hong,HUANG Wenyan,YU Jian,ZHANG Ying,SUN Li,WU Ying,LYU Xiaoying,XIAO Huijie,SUN Xiangjuan,HE Ping,HAN Shanshan,WANG Long,DAI Yanlin
DOI: https://doi.org/10.3969/j.issn.1006-2157.2023.04.003
2023-01-01
Abstract:Objective To investigate the safety and efficacy of a traditional Chinese medicine（TCM） treatment of pediatric Henoch-Sch9nlein purpura nephritis（HSPN）（proteinuria below the nephrotic level）.Methods This study was a prospective multicenter stratified randomized controlled trial. In total, 316 children diagnosed with HSPN were divided into the Chinese medicine group（mild: n=132; severe: n=83） and the Western medicine group（mild: n=60; severe: n=41）. Patients in the Chinese medicine group were treated with tripterygium wilfordii multiglucoside + sulfotanshinone sodium injection+Qingre Zhixue Formula, the starting dose of tripterygium wilfordii multiglucoside for the Chinese medicine mild group was 1.5 mg/（kg·d）, while that for the Chinese medicine severe group was 2 mg/（kg·d）. Patients in the Western medicine mild group were treated with low-molecular-weight heparin calcium + benazepril + dipyridamole + a TCM simulator. In addition, patients in the Western medicine severe group received prednisone. The patients were treated for 12 weeks and followed up for 36 weeks. The urinary protein levels and urinary red blood cell（RBC） count were investigated in the 4th week and the 12th week. In addition, the recurrence rate at the end of 48 weeks of follow-up was calculated, and the incidence of adverse events at the end of 12 weeks of treatment was calculated.Results The urinary protein levels in the Chinese medicine group, the Chinese medicine mild group and the Chinese medicine severe group at the 4th week and the 12th week were significantly lower than in the Western medicine group, the Western medicine mild group and the Western medicine severe group（P＜0.01）. The urinary RBC counts in the Chinese medicine group, the Chinese medicine mild group and the Chinese medicine severe group at the 4th week and the 12th week were significantly lower than in the Western medicine group, the Western medicine mild group and the Western medicine severe group（P＜0.01）. No significant difference in recurrence rate was found between the Chinese medicine group and the Western medicine group, between the Chinese medicine mild group and the Western medicine mild group, or between the Chinese medicine severe group and the Western medicine severe group. The incidence of adverse events was lower in the Chinese medicine group than in the Western medicine group, and it was lower in the Chinese medicine severe group than in the Western medicine severe group（P＜0.01）, but there was no significant difference between the Chinese and Western medicine mild groups.Conclusion Chinese medicine alone can be used to reduce urinary protein levels and urinary RBC counts in both mild and severe HSPN. The effect of Chinese medicine on proteinuria was quicker than that of Western medicine, and the incidence of adverse events was significantly lower in the Chinese medicine group than in the Western medicine group. The stepwise Chinese medicine scheme, which is mainly based on tripterygium wilfordii multiglucoside combined with Qingre Zhixue Formula, shows an excellent curative effect and fewer adverse events, indicating it is worthy of clinical promotion.